Floatz logo

Meperidine

Hematuria

Taha UçarSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hematuria cohort.

Asset / SponsorPhaseRating
DICLOFENAC
Taha Uçar
Phase 4BB
Tranexamic Acid
Fraser Health
Phase 1/2CCC

Same molecule, other indications

Meperidine is also rated in:

choledocholithiasisDormant
BBB
Indicative ·
72 / 100
View asset →
pancreatitisDormant
BB
Indicative ·
68 / 100
View asset →
Major Depression DisordersDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →